Printer Friendly

ENDOTRONICS DISCONTINUES DISTRIBUTION AGREEMENT WITH VENTREX LABORATORIES -- SIGNS LETTER OF INTENT WITH NORTHUMBRIA BIOLOGICALS

 ENDOTRONICS DISCONTINUES DISTRIBUTION AGREEMENT WITH VENTREX
 LABORATORIES -- SIGNS LETTER OF INTENT WITH NORTHUMBRIA BIOLOGICALS
 MINNEAPOLIS, Dec. 20 /PRNewswire/ -- Endotronics, Inc. (NASDAQ: ENDO) announced today changes in its agreements to distribute serum-free media to biotechnology markets.
 Endotronics has signed a letter of intent with Northumbria Biologicals, Ltd. of Cramlington, U.K. to become the non-exclusive distributor of Northumbria serum-free and protein-free media products to research and production facilities in the United States. Northumbria Biologicals, Ltd. is part of the Integra Biotechnology Division of INTEGRA Holding Ltd. ("INTEGRA") of Switzerland, a significant shareholder of Endotronics.
 Under a distribution agreement signed in 1989, Endotronics served as the exclusive distributor of serum-free media products of Ventrex Laboratories, Inc., recently acquired by Hycor Biomedical, Inc. Endotronics will no longer be distributing Ventrex serum-free media products. This distribution agreement produced revenues of more than $1 million for fiscal 1990 and 1991 combined.
 Richard E. Sakowicz, Endotronics president and chief operating officer, said: "We are looking forward to finalizing our agreement with Northumbria. In addition to serving the same markets with Northumbria's serum-free and protein-free media products, Endotronics and Northumbria are discussing the cooperative development of additional biotechnology products and services to meet the needs of the biotechnology market."
 Endotronics, Inc., headquartered in Minneapolis, is a recognized industry leader in hollow fiber cell culture instrumentation. With more than 650 instruments installed worldwide, the company's products and services are used by biotechnology, pharmaceutical, and diagnostic companies and research centers for production of mammalian cell-derived human health care products.
 -0- 12/20/91
 /CONTACT: Yvonne L. Marschner-Bova of Endotronics, 313-871-7350/
 (ENDO) CO: Endotronics, Inc.; Ventrex Laboratories, Inc. ST: Minnesota IN: MTC SU:


KK -- DE028 -- 4517 12/20/91 16:31 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 20, 1991
Words:282
Previous Article:TWA TO SELL TWO LONDON ROUTES TO USAIR; TWA TO LEASE THREE B-767'S
Next Article:BG&E REPORTS EARNINGS FOR THE 11 MONTHS ENDED NOV. 30, 1991
Topics:


Related Articles
ENDOTRONICS, INC. SIGNS AGREEMENT WITH GOODWIN INSTITUTE FOR CANCER RESEARCH INC. TO EXPAND CONTRACT PRODUCTION SERVICES
ENDOTRONICS, INC. INTRODUCES ACUMOUSE CELL CULTURE INSTRUMENT -- COST-EFFECTIVE SUBSTITUTE FOR LABORATORY MICE
UNIVERSITY OF MINNESOTA AND ENDOTRONICS, INC. TO COLLABORATE ON DEVELOPMENT OF BIO-ARTIFICIAL DEVICE TO REPLACE LIVER FUNCTION
ENDOTRONICS, INC. REPORTS RESULTS FOR FIRST QUARTER ENDED DEC. 31, 1991
ENDOTRONICS, INC. RECEIVES $1 MILLION PURSUANT TO INVESTMENT AGREEMENT WITH INTEGRA HOLDING AG OF SWITZERLAND
ENDOTRONICS SIGNS PRODUCTION AND MARKETING AGREEMENT WITH HELIXYS
ENDOTRONICS, INC. ANNOUNCES PURCHASE OF OPTICELL(TM) CELL CULTURE PRODUCT LINE FROM CHARLES RIVER LABORATORIES
ENDOTRONICS, INC. AND WHEATON SCIENCE PRODUCTS, INC. ANNOUNCE MARKETING AND DISTRIBUTION AGREEMENT
ENDOTRONICS, INC. SIGNS STRATEGIC COOPERATION AGREEMENT WITH TECNOMARA AG OF SWITZERLAND
ENDOTRONICS, INC. AGREES TO PURCHASE VERAX PRODUCT LINE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters